• Andreas S Triantafyllis, Danai Sfantou, Eleni Karapedi, Katerina Peteinaki, Sotirios C Kotoulas, Richard Saad, Petros N Fountoulakis, Konstantinos Tsamakis, Dimitrios Tsiptsios, Loukianos Rallidis, James N Tsoporis, Dimitrios Varvarousis, Eftychia Hamodraka, Andreas Giannakopoulos, Leonidas E Poulimenos, and Ignatios Ikonomidis.
• Department of Cardiology, Asklepeion General Hospital, Athens, Greece.
• Med Princ Pract. 2024 Sep 20: 1121-12.

AbstractPatients with SARS-CoV-2 infection carry an increased risk of cardiovascular disease encompassing various implications, including acute myocardial injury or infarction, myocarditis, heart failure, and arrhythmias. A growing volume of evidence correlates SARS-CoV-2 infection with myocardial injury, exposing patients to higher mortality risk. SARS-CoV-2 attacks the coronary arterial bed with various mechanisms including thrombosis/rupture of preexisting atherosclerotic plaque, de novo coronary thrombosis, endotheliitis, microvascular dysfunction, vasculitis, vasospasm, and ectasia/aneurysm formation. The angiotensin-converting enzyme 2 receptor plays pivotal role on the cardiovascular homeostasis and the unfolding of COVID-19. The activation of immune system, mediated by proinflammatory cytokines along with the dysregulation of the coagulation system, can pose an insult on the coronary artery, which usually manifests as an acute coronary syndrome (ACS). Electrocardiogram, echocardiography, cardiac biomarkers, and coronary angiography are essential tools to set the diagnosis. Revascularization is the first-line treatment in all patients with ACS and obstructed coronary arteries, whereas in type 2 myocardial infarction treatment of hypoxia, anemia and systemic inflammation are indicated. In patients presenting with coronary vasospasm, nitrates and calcium channel blockers are preferred, while treatment of coronary ectasia/aneurysm mandates the use of antiplatelets/anticoagulants, corticosteroids, immunoglobulin, and biologic agents. It is crucial to untangle the exact mechanisms of coronary involvement in COVID-19 in order to ensure timely diagnosis and appropriate treatment. We have reviewed the current literature and provide a detailed overview of the pathophysiology and clinical spectrum associated with coronary implications of SARS-COV-2 infection.© 2024 The Author(s). Published by S. Karger AG, Basel.

36 keywords...

hide…